ALDR - Alder BioPharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $8.37. This is a potential upside of $8.37 (0%) from yesterday's end of day stock price of $0.

Alder BioPharmaceuticals's activity chart (see below) currently has 45 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.81% with an average time for these price targets to be met of 82.33 days.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Sep-2019. First documented stock forecast 02-Jun-2014.

Best performing analysts who are covering ALDR - Alder BioPharmaceuticals:

Brian Abrahams Difei Yang Joseph Schwartz Danielle Brill Matthew Luchini Sumant Kulkarni

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

20

$1.12 (5.93%)

20

4 years 7 months 2 days ago

0/3 (0%)

$1.5 (8.11%)

Buy

41

4 years 10 months 21 days ago

0/3 (0%)

$21.83 (113.88%)

Buy

21

$2.12 (11.23%)

27

4 years 11 months 16 days ago

2/11 (18.18%)

$8.76 (71.57%)

155

Buy

28

$9.12 (48.31%)

28

5 years 1 months 24 days ago

0/5 (0%)

$13.29 (90.35%)

Hold

15

$-3.88 (-20.55%)

29

5 years 6 months 6 days ago

1/6 (16.67%)

$1.73 (13.04%)

339

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALDR (Alder BioPharmaceuticals) average time for price targets to be met?

On average it took 82.33 days on average for the stock forecasts to be realized with a an average price target met ratio 5.81

Which analyst has the current highest performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the current lower performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on ALDR (Alder BioPharmaceuticals)?

Brian Abrahams works at RBC and has 17 price targets and 13 ratings on ALDR

Which analyst is the currently most bullish on ALDR (Alder BioPharmaceuticals)?

Danielle Brill with highest potential upside - $9.12

Which analyst is the currently most reserved on ALDR (Alder BioPharmaceuticals)?

Difei Yang with lowest potential downside - -$3.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?